TEVA - Alvotech to produce Humira biosimilar for Cigna's Quallent
2024-04-30 11:56:42 ET
More on Alvotech
- Alvotech: Consider Buying As Positive Q1 Earnings Release Likely
- Alvotech (ALVO) Q4 2023 Earnings Call Transcript
- Alvotech/Teva bring new partner to expand access for Humira biosimilar in U.S.
- FDA approves Alvotech biosimilar of J&J top-selling drug Stelara
- Seeking Alpha’s Quant Rating on Alvotech